HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José M Ferro Selected Research

Transient Ischemic Attack

1/2021Neurological complications of cardiomyopathies.
1/2017Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.
4/2003Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José M Ferro Research Topics

Disease

25Stroke (Strokes)
06/2021 - 04/2003
20Venous Thrombosis (Deep-Vein Thrombosis)
06/2024 - 01/2008
15Intracranial Sinus Thrombosis (Sinus Thrombosis)
12/2023 - 01/2003
15Ischemic Stroke
09/2021 - 07/2008
12Thrombocytopenia (Thrombopenia)
12/2023 - 09/2021
8Seizures (Absence Seizure)
01/2021 - 03/2008
6Hemorrhage
12/2023 - 04/2003
5Infections
06/2021 - 03/2008
5Endocarditis
04/2020 - 01/2014
4Intracranial Hemorrhages (Intracranial Hemorrhage)
10/2023 - 01/2014
4Atrial Fibrillation
06/2014 - 02/2003
3Thrombosis (Thrombus)
04/2024 - 03/2008
3Embolic Stroke
07/2021 - 10/2011
3Transient Ischemic Attack
01/2021 - 04/2003
3Hypertension (High Blood Pressure)
11/2017 - 03/2010
3Cerebral Hemorrhage
01/2016 - 02/2007
2Hematoma
04/2024 - 10/2011
2Parkinson Disease (Parkinson's Disease)
08/2022 - 10/2020
2COVID-19
11/2021 - 09/2021
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
09/2021 - 02/2013
2Neoplasms (Cancer)
09/2021 - 09/2014
2Headache (Headaches)
01/2021 - 02/2007
2Ataxia (Dyssynergia)
01/2021 - 10/2014
2Neurologic Manifestations (Neurological Manifestations)
01/2021 - 01/2021
2Demyelinating Diseases (Demyelinating Disease)
01/2021 - 10/2014
2Infarction (Infarctions)
01/2019 - 01/2006
1Sepsis (Septicemia)
01/2023
1Drug-Related Side Effects and Adverse Reactions
01/2023
1Sickle Cell Anemia (Hemoglobin S Disease)
09/2021
1Hematologic Diseases (Blood Diseases)
09/2021
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
09/2021
1Leukemia
09/2021
1Lymphoma (Lymphomas)
09/2021
1Multiple Myeloma
09/2021
1Thrombotic Thrombocytopenic Purpura
09/2021
1Venous Thromboembolism
01/2021
1Multiple Sclerosis
01/2021
1Muscle Cramp (Cramp)
01/2021
1Malnutrition (Nutritional Deficiencies)
01/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Myotonia
01/2021
1Dementia (Dementias)
01/2021
1Paralysis (Palsy)
01/2021
1Delirium
01/2021
1Deafness (Deaf Mutism)
01/2021
1Cognitive Dysfunction
01/2021
1Muscle Weakness
01/2021
1Syncope (Fainting)
01/2021
1Atrophy
01/2021
1Aneurysm (Aneurysms)
01/2019
1Heart Neoplasms
01/2019
1Fibrosis (Cirrhosis)
11/2018

Drug/Important Bio-Agent (IBA)

10VaccinesIBA
12/2023 - 09/2021
10AnticoagulantsIBA
01/2023 - 01/2003
10Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 02/2007
6Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2006
5DabigatranFDA Link
01/2022 - 10/2018
4Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2022 - 03/2008
4Warfarin (Coumadin)FDA LinkGeneric
01/2022 - 10/2018
4ChAdOx1 nCoV-19IBA
01/2022 - 11/2021
4Anticonvulsants (Antiepileptic Drugs)IBA
09/2017 - 03/2008
3Vitamin KFDA Link
01/2023 - 03/2008
3Oral ContraceptivesIBA
01/2023 - 09/2014
3AntibodiesIBA
01/2022 - 01/2021
3EnzymesIBA
01/2021 - 02/2012
3danaparoid (Orgaran)FDA Link
01/2020 - 03/2010
3vinyltriethoxysilane (VTES)IBA
12/2019 - 09/2010
2Intravenous Immunoglobulins (IVIG)FDA Link
12/2023 - 10/2023
2Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 01/2014
2COVID-19 VaccinesIBA
01/2022 - 01/2022
2mRNA VaccinesIBA
01/2022 - 11/2021
2Ad26COVS1IBA
01/2022 - 01/2022
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2021 - 03/2010
2SteroidsIBA
01/2021 - 01/2008
2Metronidazole (Metric)FDA LinkGeneric
01/2021 - 01/2009
2Brain Natriuretic Peptide (Natrecor)FDA Link
10/2020 - 06/2014
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 04/2003
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2019 - 04/2016
1Factor XI (Plasma Thromboplastin Antecedent)IBA
06/2024
1BNT162 VaccineIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1thiamine triphosphorate (TTP)IBA
09/2021
1Monoclonal AntibodiesIBA
09/2021
1Platelet Factor 4IBA
09/2021
1AcetylcholinesteraseIBA
01/2021
1Retinaldehyde (Retinal)IBA
01/2021
1Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2021
1IntegrinsIBA
01/2021
1ButyrylcholinesteraseIBA
01/2021
1RivaroxabanIBA
01/2019
1GadoliniumIBA
11/2018

Therapy/Procedure

11Therapeutics
11/2021 - 01/2003
6Thrombectomy
09/2021 - 04/2016
2Length of Stay
04/2024 - 06/2018
2Craniotomy
04/2024 - 10/2011
2Secondary Prevention
06/2021 - 06/2021
2Carotid Endarterectomy
11/2017 - 01/2017
2Contraindications
03/2003 - 02/2003
1Conservative Treatment
01/2019